Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01302496
What this trial is testing

Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Bart Neyns 39
Not applicableUnknownNCT05062096
What this trial is testing

Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence

Who this might be right for
Melanoma
Assistance Publique - Hôpitaux de Paris 220
Not applicableAvailableNCT05398640
What this trial is testing

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT04771520
What this trial is testing

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8+26 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT07436390
What this trial is testing

IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma

Who this might be right for
Metastatic MelanomaMalignant MelanomaSkin Cancer
Institute of Oncology Ljubljana 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06327698
What this trial is testing

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

Who this might be right for
Melanoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00925132
What this trial is testing

Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat

Who this might be right for
Metastatic Melanoma
University of Iowa 39
Testing effectiveness (Phase 2)Ended earlyNCT00670748
What this trial is testing

Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer

Who this might be right for
Metastatic MelanomaMetastatic Renal Cell CancerMetastatic Cancer
National Cancer Institute (NCI) 45
Not applicableEnded earlyNCT04734704
What this trial is testing

Defining the Role of the Skin Microbiome in Immune-related Adverse Events

Who this might be right for
VitiligoSkin Melanoma
University Hospital, Bordeaux 57
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Testing effectiveness (Phase 2)UnknownNCT03269565
What this trial is testing

International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma

Who this might be right for
Melanoma
Biocad 126
Testing effectiveness (Phase 2)Ended earlyNCT02375984
What this trial is testing

A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas

Who this might be right for
Metastatic Melanoma
Saint John's Cancer Institute 1
Not applicableActive Not RecruitingNCT07428252
What this trial is testing

Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Institute of Oncology Ljubljana 150
Not applicableStudy completedNCT07256184
What this trial is testing

Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

Who this might be right for
Metastatic Malignant Melanoma
Ankara Etlik City Hospital 232
Testing effectiveness (Phase 2)Ended earlyNCT01273181
What this trial is testing

MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes

Who this might be right for
Metastatic CancerMetastatic Renal CancerMetastatic Melanoma
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT02716948
What this trial is testing

SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the SpineStage IV Skin Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Not applicableStudy completedNCT03155217
What this trial is testing

Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old

Who this might be right for
Metastatic Melanoma
University Hospital, Montpellier 358
Testing effectiveness (Phase 2)Study completedNCT00003308
What this trial is testing

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT05806268
What this trial is testing

Patient Characteristics, Associated Factors, and Clinical Outcomes of Prescribing Encorafenib and Binimetenib Versus Dabrafenib and Trametinib Among BRAF v600 Mutated Metastatic Melanoma Patients

Who this might be right for
BRAF v600 Mutated Metastatic Melanoma
Novartis Pharmaceuticals 214
Very early researchLooking for participantsNCT04741997
What this trial is testing

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation
H. Lee Moffitt Cancer Center and Research Institute 50
Next Page
50